In this section
Pediatric translational research unit
The Pediatric TRU is located on the 2nd floor of the center tower of Children's Milwaukee campus. You can access the TRU by either taking the S elevators to the 2nd floor or if you are taking the sky walk, follow signage to TRU.
The Pediatric TRU provides nursing care and coordination for research subjects and their families. Care, from infancy through adulthood, is individualized to meet a variety of research needs.
TRU appointment scheduling >>>
TRU Services:
- Research operations and training support - EPIC credentialed research trainer, IRBnet navigation assistance, budget consultation, FDA regulation assistance, and monitoring support for IND/IDE studies.
- Nursing support - coordination and study support
- IV starts, Investigation Drug Administration, Cellular and non-oncology gene therapy, and phlebotomy - Ability to draw clinical labs at the time of the research draw.
- 12 Lead ECG support (not reading/interpreting)
- Simple lab spinning, storing, and shipping of specimens.
- TRU Lab: designated as a BSL 2 lab, the lab contains: refrigerated and standard centrifuge machines, Baker Hood for maximum safety when processing specimens and sterile alliquoting, GSPMC DNA sample pick up site, and all staff are IATA/DOT trained.
- All RNs are PALS certified nurses
Medical director: Dr. James Verbsky (414) 266-6701 |
|
Manager: |
|
Research operations specialist: Jeff Crawford, CRC (414) 266-7254 |
Hours:
The Pediatric TRU is open Monday, Tuesday, Thursday & Friday 0730-1600 and Wednesday 0730-1700. Additional requests for services outside these times can be discussed with Tara Murphy, TRU Manager.
Study start up:
Whenever you wish to initiate a study using the TRU or are considering using the TRU, please contact: Tara Murphy and/or Jeff Crawford to set up a meeting for initial conversations.
P-TRU provides a variety of support for both funded and unfunded research. The P-TRU supports researchers of both National Institutes of Health-funded studies and pilot studies that may lead to future NIH funding, as well as other peer-reviewed, patient-oriented research and clinical trials.